The molecular analysis of BRCA1 and BRCA2

Next-generation sequencing supersedes conventional approaches

Valeria D'Argenio, Maria Valeria Esposito, Antonella Telese, Vincenza Precone, Flavio Starnone, Marcella Nunziato, Piergiuseppe Cantiello, Mariangela Iorio, Eloisa Evangelista, Massimiliano D'Aiuto, Alessandra Calabrese, Giulia Frisso, Giuseppe D'Aiuto, Francesco Salvatore

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Accurate and sensitive detection of BRCA1/2 germ-line mutations is crucial for the clinical management of women affected by breast cancer, for prevention and, notably, also for the identification of at-risk healthy relatives. The most widely used methods for BRCA1/. 2 molecular analysis are Sanger sequencing, and denaturing high performance liquid chromatography (dHPLC) followed by the Sanger method. However, recent findings suggest that next-generation sequencing (NGS)-based approaches may be an efficient tool for diagnostic purposes. In this context, we evaluated the effectiveness of NGS for BRCA gene analysis compared with dHPLC/Sanger sequencing. Methods: Seventy women were screened for BRCA1/2 mutations by both dHPLC/Sanger sequencing and NGS, and the data were analyzed using a bioinformatic pipeline. Results: Sequence data analysis showed that NGS is more sensitive in detecting BRCA1/2 variants than the conventional procedure, namely, dHPLC/Sanger. Conclusion: Next-generation sequencing is more sensitive, faster, easier to use and less expensive than the conventional Sanger method. Consequently, it is a reliable procedure for the routine molecular screening of the BRCA1/2 genes.

Original languageEnglish
Pages (from-to)221-225
Number of pages5
JournalClinica Chimica Acta
Volume446
DOIs
Publication statusPublished - 2015

Fingerprint

High performance liquid chromatography
High Pressure Liquid Chromatography
Genes
Bioinformatics
BRCA1 Gene
Screening
Germ-Line Mutation
Pipelines
Computational Biology
Sequence Analysis
Breast Neoplasms
Mutation

Keywords

  • BRCA1
  • BRCA2
  • DHPLC
  • Method comparison in molecular diagnostics
  • Molecular diagnostics
  • Next-generation sequencing

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

D'Argenio, V., Esposito, M. V., Telese, A., Precone, V., Starnone, F., Nunziato, M., ... Salvatore, F. (2015). The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches. Clinica Chimica Acta, 446, 221-225. https://doi.org/10.1016/j.cca.2015.03.045

The molecular analysis of BRCA1 and BRCA2 : Next-generation sequencing supersedes conventional approaches. / D'Argenio, Valeria; Esposito, Maria Valeria; Telese, Antonella; Precone, Vincenza; Starnone, Flavio; Nunziato, Marcella; Cantiello, Piergiuseppe; Iorio, Mariangela; Evangelista, Eloisa; D'Aiuto, Massimiliano; Calabrese, Alessandra; Frisso, Giulia; D'Aiuto, Giuseppe; Salvatore, Francesco.

In: Clinica Chimica Acta, Vol. 446, 2015, p. 221-225.

Research output: Contribution to journalArticle

D'Argenio, V, Esposito, MV, Telese, A, Precone, V, Starnone, F, Nunziato, M, Cantiello, P, Iorio, M, Evangelista, E, D'Aiuto, M, Calabrese, A, Frisso, G, D'Aiuto, G & Salvatore, F 2015, 'The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches', Clinica Chimica Acta, vol. 446, pp. 221-225. https://doi.org/10.1016/j.cca.2015.03.045
D'Argenio, Valeria ; Esposito, Maria Valeria ; Telese, Antonella ; Precone, Vincenza ; Starnone, Flavio ; Nunziato, Marcella ; Cantiello, Piergiuseppe ; Iorio, Mariangela ; Evangelista, Eloisa ; D'Aiuto, Massimiliano ; Calabrese, Alessandra ; Frisso, Giulia ; D'Aiuto, Giuseppe ; Salvatore, Francesco. / The molecular analysis of BRCA1 and BRCA2 : Next-generation sequencing supersedes conventional approaches. In: Clinica Chimica Acta. 2015 ; Vol. 446. pp. 221-225.
@article{db542ecee42d4baa8fd5792eeb110f34,
title = "The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches",
abstract = "Background: Accurate and sensitive detection of BRCA1/2 germ-line mutations is crucial for the clinical management of women affected by breast cancer, for prevention and, notably, also for the identification of at-risk healthy relatives. The most widely used methods for BRCA1/. 2 molecular analysis are Sanger sequencing, and denaturing high performance liquid chromatography (dHPLC) followed by the Sanger method. However, recent findings suggest that next-generation sequencing (NGS)-based approaches may be an efficient tool for diagnostic purposes. In this context, we evaluated the effectiveness of NGS for BRCA gene analysis compared with dHPLC/Sanger sequencing. Methods: Seventy women were screened for BRCA1/2 mutations by both dHPLC/Sanger sequencing and NGS, and the data were analyzed using a bioinformatic pipeline. Results: Sequence data analysis showed that NGS is more sensitive in detecting BRCA1/2 variants than the conventional procedure, namely, dHPLC/Sanger. Conclusion: Next-generation sequencing is more sensitive, faster, easier to use and less expensive than the conventional Sanger method. Consequently, it is a reliable procedure for the routine molecular screening of the BRCA1/2 genes.",
keywords = "BRCA1, BRCA2, DHPLC, Method comparison in molecular diagnostics, Molecular diagnostics, Next-generation sequencing",
author = "Valeria D'Argenio and Esposito, {Maria Valeria} and Antonella Telese and Vincenza Precone and Flavio Starnone and Marcella Nunziato and Piergiuseppe Cantiello and Mariangela Iorio and Eloisa Evangelista and Massimiliano D'Aiuto and Alessandra Calabrese and Giulia Frisso and Giuseppe D'Aiuto and Francesco Salvatore",
year = "2015",
doi = "10.1016/j.cca.2015.03.045",
language = "English",
volume = "446",
pages = "221--225",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - The molecular analysis of BRCA1 and BRCA2

T2 - Next-generation sequencing supersedes conventional approaches

AU - D'Argenio, Valeria

AU - Esposito, Maria Valeria

AU - Telese, Antonella

AU - Precone, Vincenza

AU - Starnone, Flavio

AU - Nunziato, Marcella

AU - Cantiello, Piergiuseppe

AU - Iorio, Mariangela

AU - Evangelista, Eloisa

AU - D'Aiuto, Massimiliano

AU - Calabrese, Alessandra

AU - Frisso, Giulia

AU - D'Aiuto, Giuseppe

AU - Salvatore, Francesco

PY - 2015

Y1 - 2015

N2 - Background: Accurate and sensitive detection of BRCA1/2 germ-line mutations is crucial for the clinical management of women affected by breast cancer, for prevention and, notably, also for the identification of at-risk healthy relatives. The most widely used methods for BRCA1/. 2 molecular analysis are Sanger sequencing, and denaturing high performance liquid chromatography (dHPLC) followed by the Sanger method. However, recent findings suggest that next-generation sequencing (NGS)-based approaches may be an efficient tool for diagnostic purposes. In this context, we evaluated the effectiveness of NGS for BRCA gene analysis compared with dHPLC/Sanger sequencing. Methods: Seventy women were screened for BRCA1/2 mutations by both dHPLC/Sanger sequencing and NGS, and the data were analyzed using a bioinformatic pipeline. Results: Sequence data analysis showed that NGS is more sensitive in detecting BRCA1/2 variants than the conventional procedure, namely, dHPLC/Sanger. Conclusion: Next-generation sequencing is more sensitive, faster, easier to use and less expensive than the conventional Sanger method. Consequently, it is a reliable procedure for the routine molecular screening of the BRCA1/2 genes.

AB - Background: Accurate and sensitive detection of BRCA1/2 germ-line mutations is crucial for the clinical management of women affected by breast cancer, for prevention and, notably, also for the identification of at-risk healthy relatives. The most widely used methods for BRCA1/. 2 molecular analysis are Sanger sequencing, and denaturing high performance liquid chromatography (dHPLC) followed by the Sanger method. However, recent findings suggest that next-generation sequencing (NGS)-based approaches may be an efficient tool for diagnostic purposes. In this context, we evaluated the effectiveness of NGS for BRCA gene analysis compared with dHPLC/Sanger sequencing. Methods: Seventy women were screened for BRCA1/2 mutations by both dHPLC/Sanger sequencing and NGS, and the data were analyzed using a bioinformatic pipeline. Results: Sequence data analysis showed that NGS is more sensitive in detecting BRCA1/2 variants than the conventional procedure, namely, dHPLC/Sanger. Conclusion: Next-generation sequencing is more sensitive, faster, easier to use and less expensive than the conventional Sanger method. Consequently, it is a reliable procedure for the routine molecular screening of the BRCA1/2 genes.

KW - BRCA1

KW - BRCA2

KW - DHPLC

KW - Method comparison in molecular diagnostics

KW - Molecular diagnostics

KW - Next-generation sequencing

UR - http://www.scopus.com/inward/record.url?scp=84936972267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936972267&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2015.03.045

DO - 10.1016/j.cca.2015.03.045

M3 - Article

VL - 446

SP - 221

EP - 225

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -